Global strategic partnerships in regenerative medicine

The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focus...

Full description

Saved in:
Bibliographic Details
Published in:Trends in biotechnology (Regular ed.) 2014-09, Vol.32 (9), p.436-440
Main Authors: French, Anna, Suh, Jane Y, Suh, Carol Y, Rubin, Lee, Barker, Richard, Bure, Kim, Reeve, Brock, Brindley, David A
Format: Article
Language:English
Subjects:
Alliances
Appeals
Biotechnology
cell therapies
Clinical trials
Cooperative Behavior
Diabetes
Drug Industry
Internal Medicine
Landscapes
Medicine
Partnerships
Pharmaceutical industry
Public-Private Sector Partnerships - organization & administration
Public-Private Sector Partnerships - trends
R&D
Regenerative
regenerative medicine
Regenerative Medicine - methods
Regenerative Medicine - trends
Research & development
Research - organization & administration
Research - trends
Research and development
Stem cells
strategic partnerships
translation
Transplants & implants
Universities
Widening
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focusing on agreements involving one or more private entities. A majority of the largest biopharmaceutical companies have announced strategic partnerships with a specific regenerative medicine focus, signifying the growth and widening appeal of this emerging sector.
ISSN:0167-7799
1879-3096
DOI:10.1016/j.tibtech.2014.05.007